Pramlintide Dosage Guide
Complete guide to Pramlintide dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
15 mcg – 120 mcg
Frequency
3 times per day
Total Daily Dose
45 mcg – 360 mcg
Route
subcutaneous
Cycle Length
12–52 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Type 1
Start 15mcg before meals, titrate to 30-60mcg.
Type 2
Start 60mcg, may increase to 120mcg.
Always with meal containing 30+ grams carbs or 250+ calories.
Administration Method
Subcutaneous injection immediately before major meals. Must reduce mealtime insulin by 50% when starting to prevent hypoglycemia. Never mix with insulin.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.027 ml
Syringe units: 2.7 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with Pramlintide defaults. Adjust values as needed.
Side Effects to Monitor
Nausea (very common initially), headache, anorexia, vomiting, and abdominal pain. GI effects typically improve over time.
Safety Considerations & Risks
Severe hypoglycemia risk, especially in type 1 diabetes. Boxed warning about insulin-induced severe hypoglycemia. Requires careful dose management.